Lund Melanoma Study Group
51 – 60 of 250
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
- Contribution to journal › Article
-
Mark
Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm)
- Contribution to journal › Article
-
Mark
Population-based prognostic instrument (SweMR 2.0) for melanoma-specific survival - An ideal tool for individualised treatment decisions for Swedish patients
- Contribution to journal › Article
- 2022
-
Mark
Immediate increase in perceived energy after exercise during the course of chemotherapy treatment for breast cancer
- Contribution to journal › Article
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
Transcriptomic signatures of tumors undergoing T cell attack
- Contribution to journal › Article
-
Mark
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
- Contribution to journal › Article
-
Mark
Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
- Contribution to journal › Article
-
Mark
Incidence and trends of basal cell carcinoma in Sweden : A population-based registry study
- Contribution to journal › Article
-
Mark
Physical activity, sedentary time and breast cancer risk : a Mendelian randomisation study
- Contribution to journal › Article
